MARKET

NURO

NURO

Neurometrix Inc
NASDAQ
4.379
-0.001
-0.03%
After Hours: 4.380 +0.001 +0.03% 18:00 02/14 EST
OPEN
4.360
PREV CLOSE
4.380
HIGH
4.380
LOW
4.360
VOLUME
4.82K
TURNOVER
--
52 WEEK HIGH
4.730
52 WEEK LOW
2.660
MARKET CAP
8.94M
P/E (TTM)
-0.9543
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NURO last week (0210-0214)?
Weekly Report · 9h ago
Weekly Report: what happened at NURO last week (0203-0207)?
Weekly Report · 02/10 11:20
Weekly Report: what happened at NURO last week (0127-0131)?
Weekly Report · 02/03 11:25
Weekly Report: what happened at NURO last week (0120-0124)?
Weekly Report · 01/27 11:28
Weekly Report: what happened at NURO last week (0113-0117)?
Weekly Report · 01/20 11:19
Weekly Report: what happened at NURO last week (0106-0110)?
Weekly Report · 01/13 11:20
Weekly Report: what happened at NURO last week (1230-0103)?
Weekly Report · 01/06 11:28
NeuroMetrix announces Bradley Fluegel to resign from Board
TipRanks · 12/30/2024 21:35
More
About NURO
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

Webull offers Neurometrix Inc stock information, including NASDAQ: NURO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NURO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NURO stock methods without spending real money on the virtual paper trading platform.